全文获取类型
收费全文 | 8565篇 |
免费 | 543篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 141篇 |
儿科学 | 227篇 |
妇产科学 | 341篇 |
基础医学 | 1342篇 |
口腔科学 | 143篇 |
临床医学 | 761篇 |
内科学 | 1608篇 |
皮肤病学 | 89篇 |
神经病学 | 802篇 |
特种医学 | 354篇 |
外科学 | 885篇 |
综合类 | 57篇 |
一般理论 | 3篇 |
预防医学 | 808篇 |
眼科学 | 87篇 |
药学 | 788篇 |
中国医学 | 14篇 |
肿瘤学 | 685篇 |
出版年
2021年 | 90篇 |
2020年 | 56篇 |
2019年 | 102篇 |
2018年 | 125篇 |
2017年 | 67篇 |
2016年 | 95篇 |
2015年 | 127篇 |
2014年 | 189篇 |
2013年 | 280篇 |
2012年 | 388篇 |
2011年 | 449篇 |
2010年 | 227篇 |
2009年 | 206篇 |
2008年 | 415篇 |
2007年 | 421篇 |
2006年 | 438篇 |
2005年 | 451篇 |
2004年 | 440篇 |
2003年 | 417篇 |
2002年 | 356篇 |
2001年 | 206篇 |
2000年 | 164篇 |
1999年 | 183篇 |
1998年 | 111篇 |
1997年 | 108篇 |
1996年 | 119篇 |
1995年 | 106篇 |
1994年 | 102篇 |
1993年 | 106篇 |
1992年 | 156篇 |
1991年 | 183篇 |
1990年 | 146篇 |
1989年 | 120篇 |
1988年 | 126篇 |
1987年 | 101篇 |
1986年 | 101篇 |
1985年 | 106篇 |
1984年 | 113篇 |
1983年 | 101篇 |
1982年 | 77篇 |
1981年 | 76篇 |
1980年 | 80篇 |
1979年 | 85篇 |
1978年 | 64篇 |
1977年 | 55篇 |
1976年 | 69篇 |
1975年 | 60篇 |
1974年 | 81篇 |
1973年 | 78篇 |
1972年 | 55篇 |
排序方式: 共有9135条查询结果,搜索用时 31 毫秒
11.
Willem M Lijfering Herman G Sprenger Willem J van Son Jan van der Meer 《Blood coagulation & fibrinolysis》2007,18(5):509-511
In the past few years several studies have supported an interplay between cytomegalovirus infections and a prothrombotic state. We describe a case of primary cytomegalovirus infection in an immunocompetent adult that was complicated with mesenteric vein thrombosis. Transient protein C deficiency, lupus anticoagulant and activated protein C resistance were found, in combination with a heterozygous prothrombin G20210A mutation. We discuss the possible mechanisms of cytomegalovirus-related venous thrombosis. 相似文献
12.
Ronald A. Kramp Nathalie Caron Jacqueline Genard Christelle Lejeune Egils Gulbis Arnold Herman 《European journal of pharmacology》1997,330(2-3):165-176
Renal hemodynamics were studied using an electromagnetic perivascular flow sensor in anesthetized rats injected i.v. with vehicle, 5 or 10 mg/kg body weight (b.w.) sulindac. No hemodynamic changes occurred with vehicle (n=6), but mean arterial pressure was significantly decreased (by 15 mmHg) with sulindac (n=12). In the 5 mg/kg b.w. sulindac group (n=7), renal blood flow progressively and significantly increased from 7.88±0.36 to 8.98±0.58 ml/min, except during concomitant intrarenal infusion of 3 mg/kg b.w. per h proadifen (n=7). The pressure limits for efficient and no renal blood flow autoregulation remained unchanged (approx. 100 and 80 mmHg, respectively). In the 10 mg/kg b.w. sulindac group (n=5), renal blood flow did not change but autoregulatory pressure limits were lowered by 10 mmHg 2 h after treatment (P<0.025). Also, Na+ retention was marked. Prostanoid excretion in urine was significantly reduced with either dose but basal plasma renin activity was not (about 8 ng/ml per h; n=15). When plasma renin activity was enhanced after a reduction in renal perfusion pressure (n=21), it was decreased from 11.5±1.2 to 7.4±0.2 ng/ml per h only by 10 mg/kg b.w. sulindac (P<0.05; n=6). In conclusion, differential effects of sulindac on renal hemodynamics, Na+ excretion and plasma renin activity were demonstrated. Renal hemodynamic changes could be related in part to the cytochrome P-450 arachidonic acid pathway. 相似文献
13.
Arnold Criel Gregor Verhoef Robert Vlietinck Cristina Mecucci Johan Billiet Lucienne Michaux Peter Meeus ries Louwagie Angeline Van Orshoven Achiel Van Hoof Mark Boogaerts Herman Van den Berghe & Chris De Wolf-Peeters 《British journal of haematology》1997,97(2):383-391
We analysed a group of 390 patients, diagnosed with chronic lymphocytic leukaemia (CLL). Cases were subclassified as morphologically typical and atypical CLL according to the criteria of the FAB proposal. Typical CLL cases were mostly diagnosed at a low-risk stage (Binet A/Rai 0), required no immediate treatment and expected a long survival; atypical CLL cases mostly presented at a more advanced risk stage (Binet B/Rai I–II), usually required immediate treatment and their survival was shorter. Moreover, clinical staging was of prognostic significance in typical but not in atypical cases. In typical CLL, del(11q) was the most common chromosomal abnormality (21%) whereas in atypical CLL trisomy 12 was found in about 65% of the cases documented with an abnormal karyotype. Although chromosomal abnormalities were associated with a poor survival in typical CLL, they are of no prognostic significance in atypical CLL. Based on these data, we conclude that subtyping CLL by morphology enables the identification of two groups of cases, each characterized by a specific clinical presentation, different cytogenetic abnormalities and prognostic parameters. We speculate that these two groups may represent two related, but different, diseases with different prognostic parameters and a different survival. 相似文献
14.
15.
J. G. Boonstra Johan W. van der Pijl Yves F. C. Smets Herman H. P. J. Lemkes Jan Ringers Leendert A. van Es F. J. van der Woude Jan A. Bruijn 《Transplant international》1997,10(6):451-456
To examine the incidence of interstitial and vascular
rejection in pancreas allografts and its impact on graft survival, we studied 36 percutaneous pancreas biopsies and 10 pancreas
transplantectomy specimens from 32 patients who had undergone simultaneous pancreas-kidney transplantation. Interstitial rejection
(IR) was predominantly found in the biopsies, while vascular rejection (VR) was most prominent in the transplantectomies.
Pancreas graft survival was significantly decreased for pancreas grafts that had suffered from vascular rejection when compared
to those with only interstitial rejection. Potential rejection markers, i. e., serum amylase, glucose, creatinine, and urinary
amylase, did not correlate with histological signs of rejection, although increased levels of serum amylase were, in all but
one case, associated with rejection.We conclude that a percutaneous pancreas biopsy remains the most reliable method to determine
pancreas rejection, and that by distinguishing between IR andVR, a pancreas biopsy may provide important diagnostic as well
as prognostic information.
Received: 6 March 1997 Received after revision: 5 June 1997 Accepted: 30 June 1997 相似文献
16.
A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. 总被引:17,自引:0,他引:17
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
P G Coulie F Lehmann B Lethé J Herman C Lurquin M Andrawiss T Boon 《Proceedings of the National Academy of Sciences of the United States of America》1995,92(17):7976-7980
We have identified an antigen recognized on a human melanoma by autologous cytolytic T lymphocytes. It is encoded by a gene that is expressed in many normal tissues. Remarkably, the sequence coding for the antigenic peptide is located across an exon-intron junction. A point mutation is present in the intron that generates an amino acid change that is essential for the recognition of the peptide by the anti-tumor cytotoxic T lymphocytes. This observation suggests that the T-cell-mediated surveillance of the integrity of the genome may extend to some intronic regions. 相似文献
17.
Bernhard R. Slaap Irene M. van Vliet Herman G. M. Westenberg Johan A. Den Boer 《Psychopharmacology》1996,127(1-2):353-358
Little is known about biological predictors of treatment response in panic disorder (PD). In the present study heart rate,
blood pressure, plasma cortisol and plasma MHPG were investigated at baseline in a sample of 44 PD patients as possible predictors
for nonresponse to treatment. We used a strict definition of nonresponse to find patients who did not respond at all after
12 weeks of treatment with brofaromine or fluvoxamine. Patients were considered nonresponders when they fulfilled two criteria:
they did not show a 50% reduction of agoraphobic avoidance and they still experienced panic attacks at endpoint. The variables
that differed significantly between the groups were used to predict nonresponse to drug therapy. Using this strict definition
of nonresponse, 15 patients (32.6%) were considered nonresponders. These patients were characterised by a higher plasma MHPG
concentration and a higher heart rate at baseline. These variables were subsequently used to predict nonresponse. 相似文献
18.
19.
Herman M van Praag 《The world journal of biological psychiatry》2004,5(3):155-160
Stress often precedes psychiatric disorders. This holds particularly for the group of mood disorders. A crucial question is whether stress is an epiphenomenon or a decisive factor in the causation of (certain forms of) mood disorder. Certainty about this question can only be obtained when it can be demonstrated that stress phenomena may induce changes in brain functioning similar to the ones supposedly associated with (certain forms of) depression. Since the phenomenology of stress syndromes, as well as their emotional intensity, are highly variable, careful diagnosis is a first requirement. In studies into the significance of stress in the occurrence of depression this degree of finesse has not been achieved. The major shortcomings are discussed. Those should be systematically addressed to provide this type of research with the necessary acuity 相似文献
20.
Perry D. Cohen Linda Herman Sheryl Jedlinski Peggy Willocks Paula Wittekind 《Neurotherapeutics》2007,4(3):537-544
A patient-centered paradigm for clinical research and medical care is presented as a solution to the problem of declining
innovation and increasing costs and development time in the pipeline for new therapies. Fundamental differences in values
and motivations among scientists, clinicians, industry sponsor, and patients in neurotherapeutics provide a framework for
analysis of ethical conflicts and the loss of public confidence in medical research. Parkinson advocates’ views on clinical
trial participation, perceived risks and benefits, placebo controls, and sham surgery are presented. These views reflect the
sense of urgency and the unique perspective that comes from living with this progressive, debilitating condition full time.
A patient-centered paradigm that includes authentic voices of patients as collaborators at every stage of development will
help to resolve conflicts, build trust, recruit trial participants, and accelerate new therapies. Key elements are adaptive
clinical trial methods and the development of information technology for the assessment of outcomes and surveillance of safety
over the life cycle of a medical product. Supported by the Parkinson’s Disease Foundation, the Parkinson Pipeline Project
is a grassroots group of Parkinson’s patients whose goal is to represent an authentic voice for patients in the treatment
development process. This group promotes education and communication between members of the Parkinson’s community and active
stakeholders in medical research, industry, and regulatory agencies. Its members are an example of a new breed of knowledgeable
consumers, armed with first-hand access to research findings and reinforced by on-line connections to like-minded peers throughout
the world. 相似文献